MENU
+Compare
CNADF
Stock ticker: OTC
AS OF
Nov 29 closing price
Price
$0.04
Change
-$0.00 (-0.00%)
Capitalization
30.01M

CNADF CANADABIS CAP INC Forecast, Technical & Fundamental Analysis

CNADF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for CNADF with price predictions
Jan 08, 2025

CNADF's Indicator enters downward trend

The Aroon Indicator for CNADF entered a downward trend on December 24, 2024. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 57 similar instances where the Aroon Indicator formed such a pattern. In of the 57 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis
Bullish Trend Analysis

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (58.527). P/E Ratio (0.000) is within average values for comparable stocks, (90.460). CNADF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.947). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (19.547).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CNADF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CNADF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
CNADF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
PO Box 850
Phone
+1 888 784-4621
Employees
N/A
Web
https://www.canadabis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GGLL48.551.43
+3.03%
Direxion Daily GOOGL Bull 2X Shares
QQH67.390.79
+1.19%
HCM Defender 100 Index ETF
DXJ107.701.24
+1.16%
WisdomTree Japan Hedged Equity ETF
FDFF37.800.34
+0.91%
Fidelity Disruptive Finance ETF
ESIX32.090.07
+0.22%
SPDR S&P SmallCap 600 ESG ETF

CNADF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CNADF has been loosely correlated with BJTRF. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if CNADF jumps, then BJTRF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNADF
1D Price
Change %
CNADF100%
N/A
BJTRF - CNADF
61%
Loosely correlated
N/A
STEK - CNADF
26%
Poorly correlated
+10.59%
PLSH - CNADF
21%
Poorly correlated
N/A
HLN - CNADF
15%
Poorly correlated
+0.54%
DHBUF - CNADF
7%
Poorly correlated
-0.94%
More

Groups containing CNADF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNADF
1D Price
Change %
CNADF100%
N/A
Pharmaceuticals
category (309 stocks)
-3%
Poorly correlated
+0.20%
Pharmaceuticals: Other
category (223 stocks)
-9%
Poorly correlated
+0.11%